DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

MannKind Corp (NASDAQ: MNKD)

4.52 -0.11 (-2.38%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $4.52 -2.38%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.55
Previous Close $4.63
Daily Range $4.46 - $4.64
52-Week Range $3.46 - $11.48
Market Cap $1.9B
P/E Ratio -10.29
Dividend (Yield) $0.00 (0.0%)
Volume 3,660,836
Average Daily Volume 6,731,878
Current FY EPS -$0.31




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

MannKind, Front and Center: The Best Product Doesn’t Always Equal the Best Stock

The Motley Fool's own Michael Douglass and Todd Campbell dig into MannKind Corp.'s first quarter earnings to see if MannKind is a bargain, or a bust.

Interesting MNKD Put And Call Options For July 2nd

MannKind's Afrezza Inhaled Insulin: A Game Changer For Seniors With Diabetes

Has MannKind Stock Finally Bottomed Out?

My Primary Care Provider's Take On Afrezza

MannKind Corporation: Afrezza Is Better Than Weak Launch Suggests

Wall Street Analysts Sell The Bottom In MannKind

MannKind (MNKD) in Focus: Stock Rises 10.1% in Session - Tale of the Tape

Forget MannKind Stock's Price: Here's What You Need to Focus on Instead

Is MannKind's small share price tempting you to buy? Use this simple mental test to evaluate your decision.

Morning Market Gainers

See More MNKD News...

MNKD's Top Competitors

MNKD $4.52 (-2.38%)
Current stock: MNKD
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB